Embecta Change in Accounts Payable 2021-2025 | EMBC

Embecta change in accounts payable from 2021 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Embecta Annual Change in Accounts Payable
(Millions of US $)
2024 $60
2023 $8
2022 $77
2021 $40
2020 $-4
Sector Industry Market Cap Revenue
Medical Medical Services $0.812B $1.123B
Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $151.373B 28.07
CVS Health (CVS) United States $89.823B 11.17
Elevance Health (ELV) United States $69.805B 9.39
Cencora (COR) United States $58.879B 19.61
DiDi Global (DIDIY) China $28.380B 30.15
Labcorp Holdings (LH) United States $23.110B 18.37
Natera (NTRA) United States $22.048B 0.00
BioMerieux (BMXMF) France $17.636B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $15.729B 0.00
ICON (ICLR) Ireland $14.556B 14.01
Medpace Holdings (MEDP) United States $13.083B 34.63
Solventum (SOLV) United States $12.631B 13.03
CochLear (CHEOY) Australia $12.527B 0.00
Viatris (VTRS) United States $12.417B 4.42
Revvity (RVTY) United States $10.644B 18.75
Caris Life Sciences,�Inc (CAI) United States $9.863B 0.00
Sonic Healthcare (SKHHY) Australia $9.237B 0.00
Charles River Laboratories (CRL) United States $7.854B 14.90
HealthEquity (HQY) United States $7.700B 33.73
Bausch + Lomb (BLCO) Canada $5.147B 34.62
Sotera Health (SHC) United States $4.630B 25.87
BrightSpring Health Services (BTSG) United States $4.186B 31.93
Amplifon S.p.A (AMFPF) Italy $3.937B 21.83
GeneDx Holdings (WGS) United States $3.455B 79.14
Surgery Partners (SGRY) United States $3.057B 38.45
Alignment Healthcare (ALHC) United States $2.974B 0.00
Concentras Parent (CON) United States $2.966B 18.81
Organon (OGN) United States $2.436B 2.65
Premier (PINC) United States $2.104B 19.50
Progyny (PGNY) United States $1.940B 41.02
PACS (PACS) United States $1.817B 0.00
GoodRx Holdings (GDRX) United States $1.518B 25.71
Pediatrix Medical (MD) United States $1.417B 9.46
Teladoc Health (TDOC) United States $1.276B 0.00
Omada Health (OMDA) $1.240B 0.00
Establishment Labs Holdings (ESTA) $1.132B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.962B 0.00
AMN Healthcare Services Inc (AMN) United States $0.778B 9.62
CareDx (CDNA) United States $0.648B 11.93
Performant Healthcare (PHLT) United States $0.602B 0.00
QDM (QDMI) Hong Kong, SAR China $0.598B 102.50
Nutex Health (NUTX) United States $0.515B 7.80
Agilon Health (AGL) United States $0.501B 0.00
Sonida Senior Living (SNDA) United States $0.482B 0.00
InnovAge Holding (INNV) United States $0.471B 0.00
SBC Medicals (SBC) United States $0.413B 9.07
So-Young (SY) China $0.412B 0.00
Enhabit (EHAB) United States $0.411B 27.03
COMPASS Pathways (CMPS) United Kingdom $0.391B 0.00
Oncology Institute (TOI) United States $0.334B 0.00
LifeMD (LFMD) United States $0.294B 0.00
Beauty Health (SKIN) United States $0.269B 0.00
Shoulder Innovations (SI) United States $0.184B 0.00
DocGo (DCGO) United States $0.157B 0.00
Ascend Wellness Holdings (AAWH) United States $0.116B 0.00
Sera Prognostics (SERA) United States $0.085B 0.00
KindlyMD (NAKA) United States $0.076B 0.00
Biodesix (BDSX) United States $0.060B 0.00
NeueHealth (NEUE) United States $0.059B 0.00
IceCure Medical (ICCM) Israel $0.050B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.038B 0.00
Basel Medical Group (BMGL) Singapore $0.036B 0.00
ModivCare (MODV) United States $0.027B 0.00
SeaStar Medical Holding (ICU) United States $0.022B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.011B 0.00
OSR Holdings (OSRH) United States $0.011B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.004B 0.00
Pheton Holdings (PTHL) China $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00